SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Larry Williams who wrote (31)4/11/1999 11:22:00 PM
From: Commando   of 253
 
Larry,
That's an excellent question. I wish I had the answer. With the high volume recently, my guess is that finally there is some large institutional buying taking place. People are starting to recognize LCAV as a serious player. As Summit (BEAM) starts tapering off, more attention will be given to LCAV since it will have the greater short term gains. I was told by my broker that CNBC plans to cover the Laser Correction industry, focusing on LCAV and Summits (BEAM) alliance. It should air within the next month. I would think that would give the stock even more of a boost. I will try to find out who the analysts are covering LCAV and I will let you know.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News